NANOG and ovarian carcinoma: To validate that VJ targets other CSC populations in addition to ALDH1+ CSC population, we examined the effect of VJ on expression of genes for NANOG, LGR5 and OCT4, reported to be present in ovarian cancer [12, 13, 30–34].